Reach Resources Limited (ASX:RR1) Confirms Initial Assay Results Impact Securities
Reach Resources Limited (ASX:RR1) confirms initial assay results from Murchison South have a material impact on its securities, ensuring ASX listing compliance.
Reach Resources Limited (ASX:RR1) confirms initial assay results from Murchison South have a material impact on its securities, ensuring ASX listing compliance.
4DMedical (ASX:4DX) secures Canadian approval for CT LVAS™, expanding its respiratory imaging portfolio and market reach.
Great Northern Minerals Limited (ASX:GNM) explains the recent increase in trading activity due to strategic agreements and enhanced cash position.
Noumi Limited (ASX:NOU) reports revenue slightly up and EBITDA growth in its half-year financial results, despite an increased net loss.
Neuren Pharmaceuticals (ASX:NEU) receives FDA Rare Pediatric Disease Designation for NNZ-2591 in multiple syndromes, potentially qualifying for a priority review voucher.
Atlas Arteria (ASX:ALX) announces TRIP II has filed a federal complaint alleging constitutional violations related to the Dulles Greenway.
EDU Holdings Limited (ASX:EDU) reports a 151% increase in Trimester 1, 2025 enrolments, highlighting strong growth in its higher education business.
Deep Yellow Limited (ASX:DYL) faces a fifth legal challenge in Namibia over mining license ML237, seeking to annul its environmental clearance.
Novonix Limited (ASX:NVX) responds to ASX inquiry, stating production delay for Panasonic Energy supply agreement is not material to its securities’ value.
Dart Mining NL (ASX:DTM) requests a trading halt pending a capital raise announcement, effective until 24 Feb 2025 or sooner.